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Neutron reﬂectometryThe activity of the potent but highly toxic antifungal drug Amphotericin B (AmB), used intravenously to treat sys-
temic fungal and parasitic infections, is widely accepted to result from its speciﬁc interaction with the fungal ste-
rol ergosterol. While the effect of sterols on AmB activity has been intensely investigated, the role of membrane
phospholipid composition has largely been ignored, and structural studies of nativemembranes have been ham-
pered by their complex and disordered nature.We show for theﬁrst time that the structure of fungalmembranes
derived from Pichia pastoris yeast depends on the degree of lipid polyunsaturation, which has an impact on the
structural consequences of AmB activity. AmB inserts in yeast membranes even in the absence of ergosterol,
and forms an extra-membraneous layer whose thickness is resolved to be 4–5 nm. In ergosterol-containing
membranes, AmB insertion is accompanied by ergosterol extraction into this layer. The AmB-sponge mediated
depletion of ergosterol from P. pastorismembranes gives rise to a signiﬁcant membrane thinning effect that de-
pends on the degree of lipid polyunsaturation. The resulting hydrophobic mismatch is likely to interfere with a
much broader range of membrane protein functions than those directly involving ergosterol, and suggests that
polyunsaturated lipids could boost the efﬁciency of AmB. Furthermore, a low degree of lipid polyunsaturation
leads to least AmB insertion and may protect host cells against the toxic effects of AmB. These results provide a
new framework based on lipid composition and membrane structure through which we can understand its an-
tifungal action and develop better treatments.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Millions of people suffer invasive life-threatening fungal infections
every year, but there are still only a limited number of antifungal agents,
whose application is often restricted by toxicity, antifungal resistance
and low biovailability [1,2]. The existing drugs, discovered several de-
cades ago, target the fungal sterol ergosterol, either by preferentially
binding to it in fungal membranes, or by preventing its biosynthesis.
Ergosterol is key to their function but the precise mechanism of action,
and how it is related to the toxic side effects is still a matter of debate. A
fuller understanding of the mode of functioning of the current drugs is
critical for designing better, safer antifungal therapeutics.idyl choline; PE, phosphatidyl
serine; D2O, 2H2O, heavy water
n Source ESS AB, P.O. Box 176,Amphotericin B [3] (AmB) has the broadest spectrum of antifungal
activity and has been used as an antibiotic against systemic fungal and
parasitic infections for more than 50 years [4,5] without the develop-
ment of signiﬁcant microbial resistance. The polyene structure contain-
ing one hydrophilic and one hydrophobic face [6], gives it an ability to
interact preferentially with ergosterol, but also to a lower extent with
cholesterol, giving rise to toxic side effects that are often dose-limiting
and still represent a major problem [7,8].
The classical model used to describe the AmBmode of action against
fungal cells is based on aqueous pores formedbyAmB-sterol complexes,
which make the membrane permeable and lead to cell death [9–12].
Pore formation in cholesterol-containing model membranes requires
AmB self-assembly in solution prior to membrane insertion, while it
permeabilizes ergosterol-containing membranes even as a monomer
[13–16]. The pore model has been challenged by the fact that AmB
insertion does not necessarily lead to cell death [17–20], and that ergos-
terol binding, rather thanmembrane insertion is required for antifungal
activity [21]. Since AmB also permeabilizes sterol-free membranes [22],
it has been argued that sterols could have an indirect effect through
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structural difference between cholesterol- or ergosterol-containing
membranes has however been found [27], and differences in their inter-
action with AmB have been attributed to kinetic effects [28].
Despite the large number of studies performed, there is still no direct
structural evidence to verify the formation of channels in the cell mem-
brane as the mechanism by which AmB kills fungi. Very recently a new
mechanism was proposed [29], with compelling evidence for a process
in which ergosterol is extracted from the plasma membrane into large
extra-membranous AmB aggregates. A detailed 13C-NMR study showed
that AmB is not inserted into the membranes, and instead ergosterol
moves to the membrane surface where it is more strongly associated
with AmB than the lipids. This sequestration of ergosterol interferes
with all cellular processes depending on it (e.g. endocytosis [30], vacu-
ole fusion [31] and membrane transport proteins [32]) and is proposed
to be the basis of the antifungal action of AmB, while themembrane in-
sertion of AmB is related to the toxic side effects.
The vast majority of biophysical AmB studies have been carried out
on model membranes consisting mainly of synthetic phospholipids.
The complex lipid composition of natural cell membranes is however
essential for biological functions ranging from membrane trafﬁcking
to signal transduction and inﬂuences the membrane structural organi-
sation and physical properties, important for the activity of any
membrane-binding molecule. As a natural representative of fungal or-
ganisms, we chose the well-documented yeast Pichia pastoris. We
have carried out a detailed structural investigation of the interaction
of AmB with membranes formed from native P. pastoris lipid extracts
using the technique of neutron reﬂectometry. In order to elucidate the
effects of ergosterol, membranes were reconstituted with and without
the native sterol component. Our ﬁndings are in agreement with the
newly proposed sterol-sponge mechanism [29] and provide key struc-
tural information about the consequences of sterol extraction, as well
as a direct measure of the location and amount of the antibiotic and
the sterol. We further show that the degree of lipid polyunsaturation
determines the extent of the membrane structural modiﬁcation caused
by AmB. To our knowledge, this is the ﬁrst detailed investigation of the
effect of Amphotericin B on native fungal membrane extracts probing
the full structure of the entire membrane-AmB assembly in-situ under
physiologically relevant conditions.
2. Materials and methods
2.1. Materials
Sodium chloride (purity ≥99.5%), calcium chloride dihydrate (purity
≥99.0%), Amphotericin B (from Streptomyces sp.) and all the organic
solventswere purchased fromSigmaAldrich (France) and usedwithout
further puriﬁcation. 80 × 50 × 10 mm3 silicon single crystals, polished
on the (111) face to a roughness b 3 Å were purchased from
Synchrotronix (France). Directly before use, the silicon surfaces were
cleaned by sonication in chloroform, acetone and ethanol, and by UV-
ozone treatment (30 min). H2O was taken from a purifying system
(MilliPore; resistivity N18MΩcm) and D2O (N99% purity) was provided
by the Institut Laue–Langevin (ILL).
2.2. Yeast culture
Cells culture grown as described in de Ghellinck et al. [33]. Brieﬂy,
hydrogenated and deuterated methylotrophic yeast P. pastoris were
grown in ﬂask cultures at 30 °C in light and heavy water, respectively.
A minimal medium based on basal salt medium (BSM) was used, at
pH 6.0 (Pichia fermentation process guidelines, Invitrogen, USA) con-
taining either 20 g.L−1 of h8-glycerol (Euromedex, France) in H2O or
d8-glycerol (Euriso-Top, France) in D2O. P. pastoris cells were harvested
by centrifugation at the late exponential phase, estimated by an OD600
of 120 for H yeast and 80 for D yeast [33].2.3. Extraction and separation of P. pastoris lipids
Lipidswere extracted fromyeast according to deGhellinck et al. [33].
Yeast cells were harvested by centrifugation then immediately frozen in
liquid nitrogen. Once freeze-dried, the pellet was suspended in 4 mL of
boiling ethanol for 5 min to prevent lipid degradation and lipids were
extracted by addition of 2 mL methanol and 8 mL chloroform at room
temperature [34]. The mixture was then saturated with argon and
stirred for 1 h at room temperature. After ﬁltration through
glass wool, cell remains were rinsed with 3 mL chloroform/methanol
2:1, v/v and 5mL of NaCl 1%were then added to the ﬁltrate. The chloro-
form phase containing the lipid extract was dried under argon and
stored at−20°C until further use. The lipid extract was passed ﬁrst to
a ﬂash column chromatography containing silica (Roth, mesh size
0.04–0.063mm). Amixture of chloroform and acetic acid (100:1 v/v, re-
spectively) was used to elute the apolar lipids (steryl-ester, triglycer-
ides, sterols and fatty acids). Methanol was used to elute the polar
lipids (PL, mainly phospholipids). The apolar lipid fraction was further
puriﬁed by HPLC (250 × 8 mm column, Eurospher 100 Å Si, Knauer,
France) using a mixture of hexane and isopropanol 100:1 (v/v) at
2 mL per minute. The compounds were detected by UV adsorption at
a wavelength of 208 nm [35]. The peaks appearing from the 4th to the
13th minute were collected together into a fraction which contained
the triglycerides, fatty acids and steryl ester. The peak appearing from
the 30th to the 37th minute corresponded to the eluted sterols. The
two collected fractions were controlled by TLC (hexane/diethylether/
acetic acid 70/30/1 v/v/v, detected by I2 vapour). The fraction containing
sterols was mixed with the puriﬁed polar lipids.
2.4. Lipid analysis
The phospholipid composition was determined by 2D thin layer
chromatography. The lipid extract was spotted on the TLC (Merck)
and phospholipids were resolved by two-dimensional TLC. The ﬁrst sol-
vent was chloroform:methanol:water (65:25:4, v/v) and the second
chloroform:acetone:methanol:acetic acid:water (50:20:10:10:5, v/v).
Lipids were then visualized under UV light, after spraying with 2% 8-
anilino-1-naphthalenesulfonic acid in methanol. The phospholipid
spots were scraped off, methanolyzed in acidic condition (H2SO4 2 N)
at 110 °C for one hour in the presence of 10 μg of heneicosanoic acid
used as an internal standard. The methanolysis was stopped by the ad-
dition of water to neutralize the medium. The fatty acid methyl esters
(FAME) were extracted two times after the addition of hexane, which
formed a biphasic system. The FAMEs were then separated by gas
chromatography with a ﬂame ionisation detector (Perkin Elmer) on
a BPX70 (SGE) column and quantiﬁed by comparison with the signal
of the internal standard. Fatty acidmethyl esters (FAMEs) were iden-
tiﬁed by comparing their retention times with those of hydrogenated
standards FAMEs (Sigma) and deuterated FAMEs. Standard deuterat-
ed C16:0 and C18:0 FAMEs were obtained by methanolysis respec-
tively of 1,2-dipalmitoyl(d62)-sn-glycero-3-phosphocholine and
1,2-distearoyl(d70)-sn-glycero-3-phosphocholine (Avanti).
2.5. Lipid bilayer reconstitution and interaction with AmB
The planar supported bilayers were prepared by using the vesicle
fusion method [36]. The yeast lipid extracts were dissolved in a chlo-
roform–methanol solution (2:1 v/v). The solution was dried by a
stream of nitrogen until the lipids formed a thin ﬁlm around the
glass vial walls, which was dispersed in a salt solution (NaCl
100 mM, CaCl2 20 mM) by repeated sonication pulse at 55 Hz for
30 min. Vesicles with and without ergosterol were prepared from
both unlabelled (referred to as h-lipids-sterols and h-lipids) and
deuterated (d-lipids-sterols and d-lipids) lipid extracts. The vesicle
fusion process was characterized by means of Quartz crystal micro-
balance measurements (QCM-D) [37] (Fig. S1, Supplementary
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formation of a continuous bilayer. The lipid vesicle solutions were
kept at 65 °C before the injection into the neutron sample cell. The
lipid suspension was incubated for 30 min in the neutron reﬂectivity
cells to allow the vesicles to fuse before rinsing with the salt solution
and pure water successively. The temperature was then lowered to
30 °C in order to mimic the conditions at which yeast cells were
grown. A 1 mM solution of AmB in D2O-DMSO (9:1 molar ratio)
was prepared from a 10 mM AmB stock solution in DMSO and
injected in the experimental cell after characterization of the lipid bi-
layers. The AmB was incubated for 30 min before being rinsed away
with water. The reﬂectivity was measured in three different solvent
contrasts.2.6. Neutron reﬂectometry
Neutron reﬂectometry allows the investigation of the composi-
tion proﬁle in the direction perpendicular to the membrane surface.
Reﬂectivity R is the ratio between the intensity of the reﬂected beam
over that of the incident beam, as a function of the scattering vector
Q= 4πsinθ / λ, where θ is the angle of reﬂection and λ is the neutron
wavelength. The nuclear composition of the membrane along the z-
axis is described by the neutron scattering length density, which cor-
responds to a one dimensional densitymap of the atom positions and
is sensitive to isotopic composition. The large difference between the
neutron scattering lengths of hydrogen (−3.74 fm) and deuterium
(+6.67 fm) allows the use of lipid deuteration as a means to detect
the location of different components in themembrane. Themeasure-
ments were carried out on reﬂectometer FIGARO at the ILL (Greno-
ble, France) [38] in time of ﬂight mode using a neutron wavelength
spectrum from 2 Å to 30 Å at two incident angles, 0.8° and 3.0°.
This geometry allowed covering a Q-range from 0.009 Å−1 to
0.25 Å−1, the upper limit being determined by the incoherent back-
ground from the liquid solvent. The sample cell used for the mea-
surements is a closed ﬂow cell consisting of a 10 mm thick single
crystal silicon wafer mounted onto a PEEK (polyether ether ketone)
container sandwiched between aluminium holders to allow temper-
ature control by means of water circulation. The native silicon oxide
layer of the bare silicon (111) surfaces was characterized in two sol-
vent contrasts with a known scattering length density, in this case
H2O (−0.56 × 10−6 Å−2) and D2O (6.35 × 10−6 Å−2) and used as
a reference for the lipid structures.
Neutron reﬂectivity data were ﬁtted as described previously [39]
to model structures composed of homogeneous layers correspond-
ing to the silicon oxide, water, inner lipid headgroup, tail and outer
lipid headgroup regions which each have their own thickness, scat-
tering length density, % of solvent and interfacial roughness. The
roughness describes the broadening of the interfaces and corre-
sponds to the interpenetration of neighbouring layers caused by
the diffuse distribution of the molecules. The nominal thickness
values stated for layers with roughness do not describe the full
width of the layers, which are increased by the width of the error
function used to describe the broadening (this is illustrated in the
Supplementary information Fig. S2). The neutron reﬂectivity proﬁle
was then calculated from these neutron scattering length density
models using an optical matrix calculation in the Motoﬁt program
[40], adjusting the model parameters by a genetic optimization algo-
rithm until a ﬁt to the experimental data was found by minimizing
the global χ2 in three contrasts simultaneously. The molecular vol-
ume for ergosterol obtained from crystallographic data [41] is
630.3 Å3 leading to a neutron scattering length density of 0.143
10−6 Å−2. The volume of an AmB molecule is 983 Å3 [27], which
gives a scattering length density of 1.52 × 10−6 Å−2 in H2O,
2.87 × 10−6 Å−2 in D2O and 2.5 × 10−6 Å−2 in 66% D2O due to the
13 labile protons that can exchange with the solvent.3. Results
3.1. The structure of P. pastoris membranes depends on the degree of lipid
polyunsaturation
With the purpose of studying the effect of lipid composition on the
AmB-membrane interaction, supportedmembraneswere reconstituted
from P. pastoris total lipid extracts, either in the presence or absence of
the native sterol components (mainly ergosterol), separated from the
polar lipids by HPLC (Materials andmethods section). For neutron scat-
tering analysis of the membrane structure, lipids were extracted from
P. pastoris cells cultured in both hydrogenous and fully deuterated
media, with the latter giving rise to perdeuteration of the cellularmem-
branes [33]. The phospholipid composition of the extracts was analysed
by 2D thin layer chromatography, and quantiﬁed by fatty acid methyl
ester (FAME) analysis by gas chromatography (Materials and methods
section).
The main phospholipid classes present in P. pastoris are: phosphati-
dyl–choline (PC), phosphatidyl–ethanolamine (PE), phosphatidyl–ser-
ine (PS) and phosphatidyl–inositol (PI), with phosphatidylcholines
(~50%) being the predominant class. The fatty acids, of either 16 or 18
carbons in length include a signiﬁcant fraction of unsaturated chains,
with the mono-unsaturated C18:1 oleic acid (~30%) and the polyunsat-
urated C18:2 linoleic acid (~32%) being most common. We previously
showed that, while all the phospholipid classes are present in the
same relative amount in both hydrogenous (h-lipid) and deuterated
(d-lipid) lipid extracts, P. pastoris grown in a deuterated environment
produces mainly oleic acid (54%) while those grown in hydrogenated
environment at the same temperature have a higher degree of
polyunsaturation [33]. Thus, we were able to reconstitute P. pastoris
membranes with a signiﬁcantly different degree of polyunsaturation
with and without the sterol components for the investigation of mem-
brane composition effects on AmB.
To measure the structure of single supported membranes, we used
neutron reﬂection [42] which gives a one-dimensional density proﬁle
in the direction perpendicular to the membrane surface, corresponding
to a depth distribution of the molecular components, based on differ-
ences in their nuclear isotopic composition. This allows determination
of the thicknesses, hydration and location of the lipid headgroups and
hydrocarbon chains, as well as the incorporation of other molecules
[43], in this case the ergosterol and AmB. The structure of each support-
ed bilayer reconstituted from P. pastoris lipid extracts was measured at
30 °C (the yeast growth temperature) in four different solvent contrasts
(100%water—H2O; 100% heavywater—D2O; 38% and 66%D2O) giving
four independent neutron reﬂectivity proﬁles thatwere analysed simul-
taneously using anopticalmatrixmodel to describe the neutron scatter-
ing length density proﬁle (analogous to a one-dimensional electron
density map, but describing the location of atomic nuclei) [39]. This
allowed us to derive the membrane structure in terms of the lipid scat-
tering length density, solvent content, thicknesses of the lipid chains
and headgroups). The expected molecular neutron scattering length
density of the lipid headgroups was calculated from the relative
amounts of the phospholipid classes using published molecular vol-
umes [44–46], taking into account the extent to which the polar groups
(PE, PI and PS) exchange protons/deuteriums with the subphase
(Tables S1–S3, Supplementary material), and this value was used to ﬁt
the data.
Fig. 1 shows the neutron reﬂectivity proﬁles and ﬁtted structures
of supportedmembranes (Table 1, Supplementarymaterial Table S5)
reconstituted from hydrogenous (h-lipids) and deuterium labelled
(d-lipids) P. pastoris lipid extracts either with or without the sterol
components. The hydrocarbon region (26 ± 1) Å of the h-lipid bilay-
er without ergosterol derived from P. pastoris is considerably thinner
than in model dioleoyl phosphatidyl choline (DOPC) bilayers [47],
often used in biophysical studies. The inner and outer headgroup re-
gions are somewhat more extended compared to those in model
Fig. 1.Neutron reﬂectivity proﬁles and corresponding neutron scattering length density (SLD) proﬁles illustrating the structure of supportedmembranes formed from P. pastoris lipid ex-
tracts: h-lipids – sterols (a, b), h-lipids (c, d), d-lipids – sterols (e, f) and d-lipids (g, h), deposited on silicon substrates in D2O (red squares), 66% D2O (green circles), 38% D2O (orange
triangles) and H2O (blue diamonds). The reﬂectivity proﬁles are multiplied by the fourth power of the neutron scattering vector Q, related to the angle of reﬂection θ and neutron wave-
lengthλ by Q=(4πsinθ) /λ, in order to visualize the reﬂected intensity arising from themembrane. A global ﬁt to the experimental data in all four solvent contrastswas used to reﬁne the
model structures composed of two regions for the lipid headgroups and a uniform middle layer for the lipid hydrocarbon chains, depicted schematically in b, d, f, and h.
Table 1
Structural of supported membranes reconstituted from P. pastoris lipid extracts.
Bilayer Region Thickness (Å) % v/v ergosterol % v/v AmB % v/v solvent
d-lipids Head 7 ± 1 27 ± 8
−ergosterol Chains 32 ± 1 2 ± 2
Head 7 ± 1 27 ± 8
+AmB Head 7 ± 1 29 ± 8
Chains 29 ± 1 1.6 ± 0.2⁎ 0 ± 2
Head 9 ± 1 28 ± 8
AmB 47 ± 2 91 ± 1
d-lipids Head 6 ± 1 25 ± 2
Chains 31 ± 1 3.7 ± 5.3⁎ 0 ± 1
Head 7 ± 1 20 ± 2
+AmB Head 9 ± 1 40 ± 2
Chains 30 ± 1 12 ± 5⁎ 0 ± 1
Head 6 ± 1 28 ± 2
AmB 37 ± 2 12 ± 5⁎⁎ 94 ± 1
h-lipids Head 9 ± 1 42 ± 8
−ergosterol Chains 26 ± 1 4 ± 2
Head 9 ± 1 42 ± 8
+AmB Head 8 ± 1 40 ± 8
Chains 24 ± 1 4 ± 1.5⁎ 0 ± 2
Head 7 ± 1 40 ± 8
AmB 39 ± 2 87 ± 1
h-lipids Head 7 ± 1 34 ± 8
Chains 29 ± 1 9.8 ± 5.3⁎ 1 ± 2
Head 7 ± 1 34 ± 8
+AmB Head 7 ± 1 48 ± 8
Chains 23 ± 1 – 4 ± 1.5⁎ 0 ± 2
Head 7 ± 1 34 ± 8
AmB 39 ± 2 23 ± 5⁎⁎ 77 ± 1
⁎ Relative to the lipids.
⁎⁎ Relative to AmB.
2320 A. de Ghellinck et al. / Biochimica et Biophysica Acta 1848 (2015) 2317–2325lipid bilayers (9± 1) Å [44], and have a relatively high level of hydra-
tion (42 ± 8% by volume) as a consequence of the complex
headgroup composition. The four contrasts measured allowed us to
ﬁt the neutron scattering length density for the lipid chains with a
high accuracy to (−0.140 ± 0.02) × 10−6 Å−2, which correlates
well with an estimate (−0.143 × 10−6 Å−2) calculated on the
basis of the average lipid chain volume from the lipid acyl chain com-
position (Table S4, Supplementary material). This value is relatively
low compared to that estimated for ﬂuid single phospholipid mem-
branes (e.g. (−0.21 ± 0.06) × 10−6 Å−2 for DOPC, and (−0.29 ±
0.06) × 10−6 Å−2 for POPC) [48] and arises from the presence of
polyunsaturated lipids containing fewer hydrogens.
With ergosterol included in the membrane, the h-lipid bilayer has a
thicker hydrophobic chain region (29 ± 1) Å. The value ﬁtted in this
case for the scattering length density of the lipid chains, (−0.084 ±
0.03) × 10−6 Å−2, is signiﬁcantly higher than for the pure h-lipids and
corresponds to 14.5 mol% of ergosterol (which has a scattering length
density of 0.43 × 10−6 Å−2) assuming that the presence of the sterol
does not lead to signiﬁcant changes in the lipid density. Thiswas consid-
ered to be a reasonable assumption as it has been demonstrated that
even the much higher levels of ergosterol present in Saccharomyces
cerevisiae do not change the membrane ﬂuidity [49].
The d-lipid bilayerwith no ergosterol, composed ofmainlymonoun-
saturated C18:1 lipids, has a hydrophobic thickness of (32 ± 1) Å, 6 Å
thicker than in the corresponding hydrogenous, more polyunsaturated
membrane. The thickness is also somewhat higher than the one
found in synthetic C18:1–C18:1 PC bilayers, as the deuterated lipid
extract retains a fraction of the saturated C16:0 and C18:0 chains.
The neutron scattering length density of the deuterated lipid chains,
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deuterated media produces fully perdeuterated lipids – this value
falls within 4–5% of the estimated lipid chain volume which was cal-
culated using CH2, CH3 and C = C component volumes from molecu-
lar dynamics simulations of a synthetic lipid bilayer (Table S4,
Supplementary material) [50]. The lipid headgroup layer thickness
(7 ± 1) Å is smaller than in the hydrogenous bilayer, consistent
with the lipids having a narrower tail distribution that allows them
to pack in a more similar manner to a single synthetic lipid.
The ergosterol-containing d-lipid bilayer shows less structural
variation as a consequence of the sterol component and has a similar
hydrophobic thickness (31 ± 1) Å as the d-lipid bilayer in the absence
of sterols. The lipid chain scattering length density, (6.38 ±
0.02) × 10−6 Å−2, however corresponds to only 5.5 mol% of ergosterol,
indicating that either the growth in a deuterated medium or the subse-
quent adjustment in lipid polyunsaturation is coupled to a reduction in
the sterol content. This is consistent with the effects of sterols observed
in model lipid bilayers, in which low sterol concentrations only have a
modest effect on the lipid order in ﬂuid lipid bilayers [51].
Although ergosterol leads to a thickening of both deuterated and
non-deuterated fungal membranes, a much larger effect is observed
for polyunsaturated membranes, demonstrating an interplay between
the phospholipid and sterol composition in determining membrane
structure. It is therefore crucial to analyse both membrane structure
and lipid composition in order to understand the properties of mem-
branes targeted by AmB.
Although deuteration is often thought to the perfect isomorphic re-
placement, it can lead to changes in the structure and dynamics of lipid
samples, and it is necessary to consider the differences seen between
the membrane structures in this context. The main isotope effect in
lipid samples is a shift in the phase transition temperature Tm, which
is typically by 3–4° lower in lipids with both chains per-deuterated
[52,53]. Our experiments were conducted at the yeast growth tempera-
ture of 30 °C to ensure that themembranes were in their biological ﬂuid
state, and the deuterated membrane would indeed be somewhat more
ﬂuid than the corresponding non-deuterated membrane at the same
temperature. This would typically lower the membrane thickness due
to the increased disorder of the deuterated chains. The deuterated
P. pastoris phospholipids however contain a signiﬁcantly higher propor-
tion of C18:1 chains (53%) than the non-deuterated samples (29%), at
the same time as having fewer polyunsaturated lipids, which acts to re-
duce the ﬂuidity. In fact our results show that the deuterated P. pastoris
phospholipid membranes are thicker than the non-deuterated mem-
branes, and have a structure that is much more like a synthetic DOPC
bilayer [48]. The lipid headgroup composition does not change upon
deuteration, and as the ionizable groups on the lipid headgroups have
pKa's well outside the pH range in our experiments, it is unlikely that
there are any other signiﬁcant isotope effects. It is therefore clear that
the structural differences do not arise from the deuteration, but from
the differences in lipid chain composition. We can likewise expect the
lipid composition to have a muchmore signiﬁcant effect on the interac-
tion with AmB than the deuteration of the lipids.
3.2. AmB inserts in P. pastoris membranes lacking ergosterol and forms a
thick extra-membraneous layer
AmB (1 mM), induces a signiﬁcant difference in the membrane re-
ﬂectivity proﬁles, which were measured on each lipid bilayer in three
different solvent contrasts to determine accurately the lipid chain scat-
tering length density. Fig. 2 shows the reﬂectivity curves and ﬁtted scat-
tering length density proﬁles for each sample before (in black) and after
the addition of AmB (red: 100% D2O, blue 100 H2O, green, 66% D2O)
with the results summarised in Table 1 (see also Supplementary mate-
rial, Table S5). A highly hydrated AmB layer with a variable water vol-
ume fraction of 77–95% was irreversibly bound on the surface of all
the membranes, and could not be rinsed away even with copiousquantities of water. The dimensions of this layer varied between
(37±2) Å and (47± 2) Å between the four samples, These dimensions
are larger than a single AmBmolecule, implying several possible molec-
ular orientations of AmB, as illustrated in Fig. 2. Concomitantly, only a
very slight thinning (~1 Å), of the lipid tails occurs in the h-lipid – ergos-
terol membrane (Fig. 2a,b). Unlike in the absence of AmB, the neutron
scattering length density of the hydrophobic lipid region varies with
the degree of solvent deuteration, indicating that AmB (which ex-
changes protons with the solvent), inserts into the membrane core.
The values ﬁtted for the lipid chain scattering length density –
(−0.07 ± 0.02) × 10−6 Å−2 in H2O, (−0.031 ± 0.03) × 10−6 Å−2 in
66% D2O and (−0.026 ± 0.05) × 10−6 Å−2 in 100% D2O – are signiﬁ-
cantly higher than in the absence of AmB (−0.14 ± 0.02) × 10−6
Å−2, and correspond to (4 ± 1.5) % v/v of AmB relative to the lipids.
No solvent is observed inside the membrane penetration above the de-
tection limit (±3% by volume) indicating the absence of aqueous pores.
In the deuterated d-lipid bilayers, both with and without ergosterol
(Fig. 2e, f, g, h) the ﬁrst observation is that AmB generates an interfer-
ence fringe in the reﬂectivity proﬁle at Q = 0.03 Å−1 in 100% D2O.
Since the solvent matches the neutron scattering length density of the
deuterated bilayer very closely, this makes the membrane virtually invis-
ible to neutrons, and the appearance of this fringe can only come fromhy-
drogenousmaterial, i.e. AmBmolecules. Although the reﬂectivity changes
are relatively small, it was not possible to ﬁnd a ﬁt to the datawithout the
extramembranous AmB layer. The statistical signiﬁcance of this additional
layer on the ﬁt quality was quantitied by a Hamilton R-factor test [54–56]
as described in the Supplementary information and found to be within a
99.5% conﬁdence interval. The AmB layer in contact with the d-lipids –
sterol bilayer is thicker (47 ± 2) Å than on the h-lipid-sterols bilayer,
but contrary to the hydrogenous membrane, the mainly less polyunsatu-
rated deuterated membrane becomes (3 ± 1) Å thinner in the chain
region. Less AmB (1.6 ± 0.2) % v/v) also inserts in the deuterated mem-
brane, leading to only very modest changes in the scattering length den-
sity of the chain region – from (6.61 ± 0.02) × 10−6 Å−2 to (6.55 ±
0.02) × 10−6 Å−2 in H2O, (6.54 ± 0.03) × 10−6 Å−2 in 66% D2O and
(6.55±0.05)×10−6 Å−2 in 100%D2O. Themembrane thinning indicates
that AmB prefers a smaller hydrophobic thickness than the original d-
lipid – ergosterol bilayer (32 ± 1) Å, and causes the lipids to adopt a
more disordered conformation, whereas in the more polyunsaturated h-
lipid-ergosterolmembrane is able to accommodate AmBwithout a signif-
icant structural rearrangement.3.3. Membrane thinning upon ergosterol extraction by AmB depends on
lipid polyunsaturation
In the ergosterol-containing h-lipid bilayer, AmB induces a much
larger effect (Fig. 2c,d). While an almost identical extramembranous
AmB layer ((39 ± 3) Å thick and 77 ± 1% v/v solvent) is formed, a
much more signiﬁcant thinning of the hydrophobic lipid chain region
by (6 ± 2) Å occurs. At the same time, the scattering length density of
the lipid chains ((−0.07 ± 0.02) × 10−6 Å−2 in H2O, (−0.02 ±
0.03) × 10−6 Å−2 in 66% D2O and (−0.005 ± 0.05) 10−6 Å−2 in 100%
D2O) indicates that the same amount (4 ± 1.5) % v/v of AmB inserts
as in the absence of ergosterol.
The scattering length density of the AmB layer (1.07 × 10−6 Å−2 in
H2O, 1.98 × 10−6 Å−2 in 66% D2O and 2.18 × 10−6 Å−2 in 100% D2O)
shows that (23 ± 5) % v/v of ergosterol relative to AmB, or in total
(0.54 ± 0.1) μmol m−2 ergosterol is incorporated, which corresponds
closely to the amount of ergosterol originally present within the h-
lipid membrane (0.58 ± 0.1) μmol m−2. Thus, it is apparent that all
the sterol is extracted from the membrane into the AmB sponge layer.
Considering the molecular volumes of ergosterol [41] and AmB [27], the
volume fraction of AmB inserted corresponds to approximately 1 AmB
per 4 sterols originally in the membrane, while the lipid chains expand
toﬁll the remaining space giving rise to themembrane thinningobserved.
Fig. 2.Neutron reﬂectivity proﬁles and corresponding neutron scattering length density (SLD) proﬁles from illustrating the effect of AmB on supportedmembranes formed from P. pastoris
lipid extracts P. pastoris:h-lipids– sterols (a, b), h-lipids (c, d), d-lipids– sterols (e, f) andd-lipids (g, h), before (black symbols) and after 1mMAmB injection inD2O (red squares), 66%D2O
(green circles) and H2O (blue diamonds). The cartoons in b, d, f, and h show the possible orientations of AmB corresponding to the layer thicknesses in the structures formed.
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change in reﬂectivity after the interaction with AmB is considerably
smaller than in the h-lipid bilayer. The AmB sponge layer is very similar,
(37 ± 2) Å thick, (95 ± 1) % v/v solvent, but contains (12 ± 5) % v/v
deuterated ergosterol relative to AmB. The thickness of the d-lipid
membrane however does not change upon extraction of the ergosterol
into the AmB layer. The scattering length density of the hydrophobic
chain region decreases (from (6.38 ± 0.05) × 10−6 Å−2 to (6.12 ±
0.05) × 10−6 Å−2 in D2O, (6.09 ± 0.03) × 10−6 Å−2 in 66% D2O and
(5.98 ± 0.02) × 10−6 Å−2 in H2O), which corresponds to (12 ± 5) %
v/v AmB inserted in the lipid chains, signiﬁcantlymore than in the poly-
unsaturated h-lipid membrane. This implies that for every sterol mole-
cule extracted, 2 AmB molecules insert in this membrane, indicating
that the less polyunsaturated lipid chains have a smaller ability to ex-
pand upon ergosterol removal.
Thus, AmB depletes ergosterol from P. pastorismembranes, but the
extent to which this causes the membrane structure to rearrange in
response depends on the phospholipid composition.
4. Discussion
Numerous experiments on the toxicity and side effects of
Amphotericin B have been carried out on natural membranes [5]. How-
ever, most structural studies have been performed with model
membranes usually composed of DOPC or POPC containing either er-
gosterol or cholesterol [16,57–61]. Our results show that the structure
of membranes reconstituted from lipid extracts from P. pastoris differs
considerably from these simple model membranes, and is intricately
linked to the phospholipid composition, particularly the degree of
polyunsaturation. This raises the question whether results obtainedfrom simple lipid systems are able to portray all the phenomena that re-
sult from the activity of membrane-binding pharmaceuticals such as
AmB.
In order to investigate structures formed by AmB in these complex
natural lipidmembranes in detailwe employed neutron reﬂection,mak-
ing use of the large difference in neutron scattering between hydrogen
and deuterium isotopes to achieve contrast inside the complex mem-
brane system. Unlike previous structural studies [27,60], we performed
the measurements in-situ to follow the effect of extraneously added
AmB to better reﬂect the mode of action against fungal cells (instead
of pre-mixing it in the lipid membranes). Our results provide a direct
conﬁrmation of the existence of the recently proposed extra-
membraneous AmB sponge layer [29], and reveal its dimensions with
sub-nanometre resolution as well as its high water content. We ob-
served that AmB inserts to a limited extent to P. pastoris membranes
even in the absence of sterols, but that the amount inserted and the ef-
fect on themembrane structure critically depend on the lipid chain com-
position. The amount of AmB inserted is lowest in the mainly mono-
unsaturated membranes lacking sterols, in which the hydrophobic
chain region is considerably thicker than in the naturally polyunsaturat-
ed samples, and appears to partly inhibit AmB insertion. That even very
limited AmB insertion leads tomembrane thinningpoints towards a role
for a hydrophobicmatch between AmB and themembrane in determin-
ing the extent of insertion, which has previously been suggested on the
basis of model lipid studies showing that long chain lipids inhibit the
AmB permeabilizing activity, whereas short lipids can enhance it [62].
The main sterol component in P. pastoris, ergosterol [63], has the ef-
fect of making the membranes thicker [64]. Our results show that in
complex natural lipid membranes, the structuring effect of ergosterol
depends on the chain composition of the polar phospholipids – the
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without the sterol, whereas more polyunsaturated membranes are sig-
niﬁcant thinner in the absence of ergosterol. The amount of AmB inser-
tion in ergosterol-containing membranes is not directly linked to the
fraction of sterols, but depends on the degree of lipid polyunsaturation,
with most AmB inserted in the relatively mono-unsaturated mem-
branes that contain the least sterols.
AmBextracts all the sterols from themembranes,which are incorpo-
rated in the AmB sponge layer attached to the surface of themembrane.
Most notably, the sterol depletion has a signiﬁcant thinning effect on the
naturally polyunsaturated membranes containing ergosterol, in which
case the hydrophobic thickness decreases by 20%, whereas only a mod-
est thinning is observed in less polyunsaturated membranes. Thus, the
membrane fatty acid composition seems to be an essential parameter
governing the structural modiﬁcation induced by both AmB insertion
[22,25] and ergosterol removal [29].
The ﬁnal hydrophobic thickness of the AmB-containing hydroge-
nous bilayers corresponds to the length of one AmB molecule (21 Å),
which supports themodel of a single AmB spanning the lipidmembrane
[11]. Our results, based on the interaction of AmB froma solution in con-
tact with themembranes, are different to the 4–5 Åmembrane thicken-
ing and absence of an extramembranous AmB layer, found by Foglia et
al. [27] in POPCmembranes containing 30mol% ergosterol or cholester-
ol, in which AmB was premixed with the lipids before membrane for-
mation. Our results demonstrate that AmB has several effects on lipid
membranes, including insertion, ergosterol depletion, membrane thin-
ning and extramembraneous layer formation. The results of Foglia
et al. indicate that which type of structural change is observed also de-
pends on how the lipid-AmB assembly is formed. It is therefore impor-
tant to conduct in-situ structural measurements to understand the
mechanism of AmB, as well as other membrane inserting molecules
such as pore forming [65–67] and antimicrobial peptides [68,69] and
synthetic dendrimers [70,71].
The highly hydrated AmB sponge layer that forms on the top of the
membranes has a variable thickness of 37–47 Å and contains 77–95%
solvent, but is nevertheless irreversibly bound, which can be under-
stood considering the ability of AmB to hydrogen-bond to the lipid
headgroups [72], whose relative compositionwas the same in all the in-
vestigated bilayers. Thus the similarity in the sponge layer structure de-
spite the differences in lipid chain composition is not surprising. The
structure we observed correlates well with previous observations by
AFM [73] which showed a distribution of aggregated material on the
surface of the lipid membrane. We have captured the fully hydrated
structure of the 4–5 nm AmB sponge layer in direct contact with the
membrane surface, virtually impossible to detect using TEM,which pre-
viously only revealed much larger (150–200 nm) aggregates in contact
with vesicle samples [29].While larger solution aggregates of AmB exist
at the relatively high concentration used in our study (1 mM – the crit-
ical micellisation concentration of AmB, is 10−6 M) [74], our results also
indicate that they do not interact directly with the lipid membrane but
more likely act as a reservoir for the sponge-like layer formed on the
surface of the lipid membrane, into which the ergosterol is extracted.
The solution state of AmB is known to be related to its activity and
the aggregates are thought to be the active and least toxic form [16,75,
76]. Anderson et al. [29] propose that AmB toxicity is related to the
membrane-inserted form leading to cell permeabilization, whereas
the anti-fungal effect is based on ergosterol extraction, which interferes
with all biochemical pathways depending on the sterol. Our results con-
ﬁrm conclusively that both forms of the drug coexist in membranes
formed from natural yeast lipid extracts, but that the extent to which
membrane insertion occurs depends intimately on the membrane
fatty acid composition, with a low degree of polyunsaturation partly
protecting against insertion. The thinning that occurs upon ergosterol
removal in the naturally polyunsaturated P. pastorismembranes is so
pronounced that it is likely to interferewith a broad range ofmembrane
protein functions through the introduction of a severe hydrophobicmismatch [77] in the plasma membrane [78] and the outer mitochon-
drialmembrane [63] of P. pastoris (particularly enriched in both polyun-
saturated lipids and ergosterol). A similar role has been proposed for
cholesterol in modulating ion channel function [79] and the sorting of
membrane proteins [80] based on membrane hydrophobic thickness.
This suggests, moreover, that the addition of polyunsaturated lipids to
AmB formulations could beused to boost the ability of AmB to kill fungal
cells.
5. Conclusion
In conclusion, we have presented the ﬁrst structural investigation of
AmB effects on yeast lipid membranes. As expected, the structure of the
membranes is inﬂuenced by the degree of lipid polyunsaturation but
more importantly the polyunsaturation inﬂuences their ergosterol-
dependent interaction with the antifungal agent. AmB inserts in the
membranes both in the absence and presence of ergosterol and our re-
sults reveal the dimensions of the recently proposed thick extra-
membraneous AmB sponge layer [29] with sub-nanometre resolution
as well as its high water content. In this ﬁrst study we used P. pastoris
membranes at their natural lipid and sterol composition, and our results
demonstrate that a signiﬁcant amount of detailed information can be
obtained on the parameters governing the interaction mechanism of
AmB by using neutron reﬂection. Clearly important variable to investi-
gate in the future will be the effect of the sterol and lipid composition,
which can be varied by selective membrane reconstitution.
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